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E-mail address: okayama@m.u-tokyo.ac.jp (H. OkaWhen deprived of an anchorage to the extracellular matrix, ﬁbroblasts arrest in the G1 phase with
inactivation of Cdk4/6 and Cdk2 and destruction of Cdc6, the assembler of prereplicative complexes
essential for S phase onset. How cellular anchorages control these kinases and Cdc6 stability is
poorly understood. Here, we report that in rat embryonic ﬁbroblasts, activation of mammalian tar-
get of rapamycin complex 1 by a Tsc2 mutation or overexpression of a constitutively active mutant
Rheb overrides the absence of the anchorage and stabilizes Cdc6 at least partly via activating Cdk4/6
that induces Emi1, an APC/CCdh1 ubiquitin ligase inhibitor.
Structured summary:
MINT-7890626: cdc27 (uniprotkb:Q4V8A2) physically interacts (MI:0915) with Cyclin-A (uni-
protkb:Q6AY13) by anti bait coimmunoprecipitation (MI:0006)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction activity of APC/CCdh1 is negatively regulated by Cdk4/6-inducedUnless malignantly transformed, ﬁbroblasts require an anchor-
age to the extracellular matrix (ECM) for S phase entry [1]. How-
ever, despite extensive studies, how cellular anchorage to the
ECM controls the G1–S transition has been highly elusive. When
deprived of anchorages, cells arrest in G1 with inactivation of
Cdk4/6 and Cdk2, due at least partly to repression of the Cyclin D1
and Cyclin A genes and induction of p27Kip1 [2]. Inactivation of
Cdk4/6 shuts down the genes essential or important for S phase
onset, such as Cdc6, Cyclin A, E2F1 and Emi1 [3,4]. Additionally,
expression of Cdc6, which assembles prereplicative complexes for
S phase onset [5], is terminated by facilitated proteolysis [6]. Two
ubiquitin ligases antagonistically control the G1–S transition. APC/
CCdh1 destroys Cdc6 and Cyclin A to cause G1 arrest, whereas SCFSkp2
destroys the Cdk inhibitor p27kip1 to facilitate S phase entry [7]. Thechemical Societies. Published by E
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oblastoma protein; REF, rat
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yama).Emi1 [4]. Upon anchorage deprivation, in addition to G1 arrest,
apoptosis known as anoikis takes place with activation of caspase
3 that cleaves focal adhesion components and Cdc6 [8,9].
The Tsc1/Tsc2-Rheb-mTOR pathway mediates growth factor
and metabolic signals to control cell proliferation [10]. Growth fac-
tor-activated AKT/PKB stimulates Rheb by inactivating the Tsc1/
Tsc2 complex. Stimulated Rheb activates mammalian target of rap-
amycin complex 1 (mTORC1) to phosphorylate S6 kinase 1 (S6K1)
and eIF4E binding protein (4EBP) to enhance translation. Germinal
mutation of TSC2 or TSC1 causes multiple benign tumors called
familial tuberous sclerosis, a rodent version of which occurs in Eker
rats with a Tsc2 mutation [11]. We have long been interested in
understanding how anchorage signals regulate the G1–S transition
and have recently found that the anchorage signal-linked Cdk4/6
activity and Cdc6 stability are critically controlled by the Tsc-
Rheb-mTORC1 pathway.
2. Materials and methods
2.1. Antibodies and chemicals
Anti-Cdk4 and anti-b-actin antibodies were purchased from Sig-
ma (St. Louis, MO, USA). Anti-Cdh1, anti-phospho-retinoblastomalsevier B.V. All rights reserved.
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International (Woburn, MA, USA). Anti-Cdc6 was purchased from
NeoMarkers (Fremont, CA, USA). Anti-Tsc2, anti-S6K1, anti-phos-
pho-S6K1 (Thr389), anti-phospho-Rb (Ser807/811) and anti-activated
caspase 3 (cleaved at Asp175) antibodies were purchased from Cell
Signaling Technology (Boston, MA, USA). A polyclonal antibody
detecting rat and mouse Emi1 was generated by immunizing rab-
bits with its C-terminal common 12 amino acids. The remaining
antibodies were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Rapamycin, N-acetyl-leucinyl-leucinyl-norleucinal
(ALLN) and ubiquitin were obtained from Biomol International
(PlymouthMeeting, PA, USA), and benzyloxycarbonyl-valinyl-alan-
inyl-aspartyl ﬂuoromethyl ketone (zVAD) was obtained from the
Peptide Institute (Osaka, JP).
2.2. Cell culture and plasmids
Rat embryonic ﬁbroblast (REF) and Eker (Tsc2/) rat embryonic
ﬁbroblast (Eker REF) (gifts from O. Hino) were maintained in
DMEM with 10% FCS, and when speciﬁed to culturing under
anchorage deprivation, REF and Eker REF were incubated in DMEM
containing 1.17% methylcellulose and 10% FCS. A soft agar assay
was carried out with 0.5% Noble agar on the bottom and 0.33% agar
on the top. REF and/or Eker REF cell clones constitutively express-
ing rat Cdc6, human active Rheb mutant [12], mouse Cdh1, Emil
and/or the rat counterpart of human TSC2 isoform 4 (NCBI Refer-
ence Sequence: NP_001070651.1) [13] from the cytomegalovirus
promoter were constructed by using the Retroviral Gene Transfer
and Expression System (Clontech) containing the corresponding
cDNA and an appropriate drug selectable gene.
2.3. Immunoblot detection and densitometry
Cells were lysed with SDS sample buffer followed by sonication
to fragment the DNA. The lysates were electrophoresed in SDS–
polyacrylamide gels, transferred to PVDF membranes and immu-
noblotted for targeted proteins with speciﬁc antibodies [6]. For
some samples, the intensities of immunodetected bands were
quantiﬁed with NIH Image software according to the provided
protocol.
2.4. In vitro kinase assays
Cdk2 and Cdk4/6 were immunoprecipitated with the speciﬁc
antibodies, and the activity of each kinase was assayed with a trun-
cated Rb (QED Bioscience) as a substrate followed by immunoblot
detection of Ser807/811-phosphorylated Rb for Cdk2 activity and
Ser780-phosphorylated Rb for Cdk4/6 activity [6].
2.5. Quantitative RT-PCR
Total RNA was extracted from harvested cells by using ISOGEN
(Nippon Gene). Isolated RNAs had an A260/A280 ratio of 1.86–2.1.
The PrimeScript II ﬁrst-strand cDNA Synthesis kit (Takara-Bio)
was used to synthesize ﬁrst-strand cDNA from the total RNA. For
each cDNA synthesis reaction, 2 lg of RNA was denatured at
65 C for 5 min in 10 ll of 1 mM dNTP mixture with 5 lM oligo-
dT primer and quickly chilled on ice. After the addition of 10 ll
of PrimeScript buffer containing 200 units of PrimeScript II reverse
transcriptase and 20 units of RNase inhibitor, cDNA synthesis was
carried out at 45 C for 30 min and was terminated by heating at
95 C for 5 min and subsequently cooling on ice.
Quantitative real time PCR was performed with the Smart
Cycler System (Cepheid, USA) and SYBR Premix Ex Taq (Perfect
Real Time) (Takara-Bio, JP). In parallel, RT-PCR analysis without
prior reverse transcription was performed on all RNA samples toassure exclusion of DNA contamination. The primer pairs used
were as follows: 50-gcctatgaggagccaaccta-30(F) and 50-cgctaagagc-
agctggagtag-30(R) for Cyclin D3, 50-gcacaacgcactttctttcc-30(F) and
50-tccagaagggcttcaatctg-30(R) for Cyclin D1, 50-caaagccatgcagagagt-
ca-30(F) and 50-gtcgatgacttttgaacacagg-30(R) for Emi1, 50-ctctgcc-
ggtgctatgatct-30(F) and 50-catagcatggggtgattcaa-30(R) for Cyclin A,
50-aggaaagtgcagaggggatt-30(F) and 50-cttcttgctccaggcctaac-30(R)
for E2F1 and 50-ttgtaaccaactgggacgatatgg-30(F) and 50-gatcttgatc-
ttcatggtgctagg-30(R) for b-actin. b-actin transcripts were used to
normalize variations generated during preparation of RNA and
subsequent cDNA conversion from each sample.
An ampliﬁcation reaction was performed in 25 ll of SYBR Pre-
mix EX Taq containing 0.2 lM of each of the forward and reverse
primers and 1 ll of the cDNA. To reduce variability between repli-
cates, PCR premixes, which contained all the reagents except for
cDNA, were prepared in advance and aliquoted into 25 ll Smart
Cycler Tubes (Cepheid). The thermal cycling conditions used were
15 s at 95 C for denaturation followed by 30 cycles of 15 s at 95 C,
20 s at 55 C and 46 s at 72 C for b-actin, and 40 cycles of 6 s at
95 C, 15 s at 57 C and 10 s at 72 C for the others. The speciﬁcity
of single-target ampliﬁcation was conﬁrmed by examining post-
PCR melting curves, and the relative amounts of each transcript
to b-actin RNA were determined in triplicate by using the compar-
ative CT (DDCT) method.
2.6. In vitro ubiquitylation assay
Exponentially proliferating REF-Cdc6 and Eker-Cdc6-aRheb
cells were incubated in methylcellulose medium for 24 h and col-
lected with extensive washing. The cells were then lysed with
20 mM Tris–HCl (pH 7.5) containing 100 mM NaCl, 5 mM MgCl2,
0.2% NP-40, 10% glycerol, 1 mM NaF, 1 mM Na3VO4, 0.5 mM DTT
and protease inhibitor cocktail (Sigma) and then immunoprecipi-
tated for APC/CCdh1 with the anti-Cdc27 antibody and protein G Se-
pharose beads as reported [14]. APC/CCdh1-bound protein G beads
were washed 5 times with the lysis buffer and added to 12 ll of
ubiquitylation buffer containing 50 mM Tris–HCl (pH 7.5),
2.5 mM MgCl2, 0.5 mM DTT, 20 mM ATP, ATP regenerating system
(Boston Biochem), 100 nM E1 (ibid.), 500 nM UbcH10 (ibid.),
1.5 lg/ll ubiquitin, the protease inhibitor cocktail and 50 lM ros-
covitine (Calbiochem) to suppress the kinase activity of the Cdk2-
Cyclin A complex used as a substrate. The reaction was initiated by
adding 60 ng of Cdk2-Cyclin A complex (Upstate) and took place at
30 C for 0, 10 and 50 min. After separation of products by SDS gel
electrophoresis, ubiquitylated Cyclin A was detected by immuno-
blotting with the anti-Cyclin A antibody. In parallel, the quantity
of Apc8, a component of APC/C, in the reaction samples was deter-
mined by immunoblotting.3. Results
During our studies to understand how cellular anchorage con-
trols the G1–S transition, we noticed a striking similarity of the
effects on Cdc6 stability between anchorage loss and mTORC1 inhi-
bition. When REF overexpressing exogenous Cdc6 (REF-Cdc6) were
constructed with retrovirus-mediated gene transfers and deprived
of anchorages, Cdc6 protein diminished within 24–36 h despite its
constitutive transcription from the strong cytomegalovirus pro-
moter, as previously reported in the rat ﬁbroblast line [6], and this
phenomenon was accompanied by a loss of S6K1 Thr389 phosphor-
ylation, indicative of inactivation of mTORC1 (Fig. 1A). Similarly,
when the same cell, which was grown in an anchorage-furnished
culture plate, was treated with rapamycin, an inhibitor of mTORC1,
Cdc6 diminished with rapid loss of S6K1 phosphorylation. Density
measurements showed that the levels of Cdc6 were reduced to less
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vation and rapamycin treatment, respectively. In contrast, in Eker
(Tsc2/) REF engineered similarly (Eker-Cdc6) and deprived of
anchorages, Cdc6 was stably expressed (Fig. 1B). However, when
the rat counterpart of human TSC2 isoform 4, which lacks exons
25 and 31 but can effectively suppress the onset of tuberous scle-
rosis in Eker rats [13], was re-expressed in the cell (Eker-Cdc6-
Tsc2*), it became unstable with diminished S6K1 phosphorylation,
as observed for the original REF. While the level of Cdc6 remained
within 85–110% in Eker-Cdc6, it was lowered to 10% in Eker-Cdc6-
Tsc2*, as estimated by densitometry. This suggests that the Tsc1/
Tsc2-Rheb-mTORC1 cascade was crucially involved in the control
of Cdc6 stability.
3.1. Caspase 3 is not responsible for the destruction of Cdc6 early in
methylcellulose culture
We sought to understand the mechanistic basis for this
remarkable phenomenon. To achieve this goal, we constructed
REF-Cdc6-aRheb and Eker-Cdc6-aRheb (Fig. 1C), in which REF-
Cdc6 and Eker-Cdc6 cells were further engineered to express a
constitutively active mutant Rheb (aRheb) [12] by retrovirus-
based gene transfer.
Because anchorage loss induces anoikis with activation of
caspase 3 that can fragment Cdc6, we ﬁrst investigated whether
caspase 3 was responsible for the degradation of Cdc6 withinFig. 1. Inhibition of mTORC1 destabilizes Cdc6 in the presence of anchorages, wherea
Treatment with rapamycin destabilizes Cdc6. Rapidly proliferating REF-Cdc6 was culture
(RM) in anchorage-furnished culture plates and analyzed for levels of Cdc6, S6K1 and S6
Cdc6 is stable without anchorage, but in Eker-Cdc6-Tsc2* where the Tsc2 isoform 4 is re
Eker-Cdc6-Tsc2* were cultured in MC and analyzed as in (A). (C) Effects of caspase and p
Cdc6, REF-Cdc6-aRheb, Eker-Cdc6 and Eker-Cdc6-aRheb cells, for which two independent
for 24 h and treated for 12 h with or without 75 lM zVAD and/or 90 lM ALLN. Cells we
zVAD (lane 3), zVAD with ALLN (lane 4) or ALLN (lane 5), and the levels of Cdc6 and ac36 h in methylcellulose medium by monitoring caspase 3 activa-
tion and the effects of zVAD, a pan-caspase inhibitor, and/or ALLN,
a proteasome inhibitor, on the Cdc6 levels (Fig. 1C). In REF-Cdc6,
cleavage of caspase 3 occurred slightly upon anchorage loss (see
REF-Cdc6, lane 2) and heavily with fragmentation of Cdc6 after
additional ALLN treatment (see REF-Cdc6, lane 5). zVAD alone
had no effects on Cdc6 in all of these cells regardless of mTORC1
activation (compare lanes 2 and 3 for all the cells). By contrast,
ALLN markedly stabilized Cdc6 in all of these cells (see lane 5 for
all the cells), but co-treatment with zVAD had no additional effects
besides suppression of its ALLN-induced fragmentation in REF-
Cdc6 (see REF-Cdc6, lane 4). The lack of zVAD effects was not the
result of an improper use of this compound because in the same
samples, this compound completely suppressed the anchorage
deprivation as well as the ALLN-induced caspase 3 activation (see
REF-Cdc6, lanes 3 and 4) [15]. Interestingly, activation of caspase
3 was largely suppressed in the cells where Tsc2 was inactivated
or active Rheb was overexpressed, even after ALLN treatment.
These data indicate that proteasomes and/or other ALLN-sensitive
proteases, but not caspase 3, were responsible for the destabiliza-
tion of Cdc6 detected early in methylcellulose culture. Further-
more, despite the complete destruction of Cdc6 protein,
approximately 70% of the REF-Cdc6 cells harvested at 36 h in
methylcellulose medium were viable and could form colonies after
transfer to culture dishes, indicating that cell death was not linked
to the destabilization of Cdc6.s inactivation of the Tsc2 gene stabilizes Cdc6 in the absence of anchorages. (A)
d in methylcellulose medium (MC) [Anc()] or were treated with 50 nM rapamycin
K1 Thr389 phosphorylation. b-actin was used as a loading control. (B) In Eker-Cdc6,
-expressed, Cdc6 becomes unstable. Rapidly proliferating REF-Cdc6, Eker-Cdc6 and
roteasome inhibitors on the stabilization of Cdc6. Logarithmically proliferating REF-
ly isolated clones expressing similar levels of Cdc6 were combined, incubated in MC
re collected at the start of MC culture (lane 1), 36 h after with no addition (lane 2),
tivation of caspase 3 (cleaved at Asp175) were determined by immunoblotting.
Fig. 3. Emi1 mRNA remains up-regulated, and Cyclin D1 mRNA accumulates, in
anchorage-deprived Eker-Cdc6-aRheb. Transcripts for Emi1, E2F1, Cyclins A, D1 and
D3 were extracted from MC-cultured REF-Cdc6 and Eker-Cdc6-aRheb and quanti-
ﬁed by real time RT-PCR as described in Section 2. All of the data obtained from at
least two separate experiments were normalized to the levels of b-actin mRNA and
are expressed as average values with standard deviations. Open and closed circles
denote mRNA from REF-Cdc6 and Eker-Cdc6-aRheb cells, respectively.
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anchorage deprivation on G1 cell cycle factors
Given the above results, we next examined the levels ofmajor G1
cell cycle factors and some relevant proteins expressed in these four
cells during anchorage deprivation (Fig. 2A). In anchorage-deprived
REF-Cdc6, Cdc6, Cyclin A, D-type Cyclins and E2F1 all markedly
diminished within 36 h to approximately 10%, 15%, 5-15% and less
than 5% of their original levels, respectively, as analyzed by densi-
tometry. Additionally, Rb shifted to a lower position, in agreement
with a previous report [16], and conﬁrming the data presented in
Fig. 1A and B, S6K1 lost its Thr389 phosphorylation and eventually
the protein itself, indicating inactivation of Cdk2 and mTORC1,
respectively. The levels of the remaining factors decreased to vari-
ous degrees. By contrast, in cells where mTORC1 was active, all of
these factors, including Cdc6, continued to be expressed. Addition-
ally, Emi1 was up-regulated three–fourfold over its levels in REF-
Cdc6 as estimated by densitometry. On the other hand, p27Kip1
was initially down-regulated but accumulated during anchorage
deprivation, unlike the results obtained for REF-Cdc6.
Thus, virtually all the effects of anchorage loss on these G1 cell
cycle factors were effectively suppressed by inactivation of Tsc2
or overexpression of active Rheb. However, Rb remained shifted to
a lower position, indicating that Cdk2was still inactive. By contrast,
the continuedproduction of CyclinA and E2F1 suggested that unlike
Cdk2, Cdk4 and/or Cdk6 remained active. These observations were
conﬁrmed by in vitro kinase assays (Fig. 2B). In the Eker-Cdc6-aR-
heb, Cdk2 was inactivated within 12 h of methylcellulose culture.
On the other hand, Cdk4 activitywas severely reduced but remained
present for 36 h (see Fig. 5 for Cdk6). Likely due to the persistent
Cdk2 inactivation, these mTORC1-activated REFs were still unable
to effectively proliferate in the absence of anchorages (Fig. 2C).
3.3. Emi1 mRNA remains up-regulated in anchorage-deprived Eker-
Cdc6-aRheb
We next examined whether or not the elevated Emi1 protein in
Eker-Cdc6-aRheb was at least partly ascribable to an up-regulationFig. 2. Activation of mTORC1 overrules anchorage loss and stabilizes Cdc6. (A) REF and
with active Rheb expression (REF-Cdc6-aRheb and Eker-Cdc6-aRheb) were incubated i
immunoblotting. (B) In vitro kinase assays for Cdk2 and Cdk4 in REF-Cdc6 and Eker-Cdc6
described in Section 2. (C) Eker REFs overexpressing Cdc6 alone or both Cdc6 and the ac
Eker-Cdc6-aRheb cells were cultured for 10 days in soft agar with HeLa cells as a positiof its mRNA. Like Cyclin A and E2F1, the Emi1 gene is activated by
Cdk4/6 via E2F [3,4]. Consistently, Emi1 mRNA was up-regulated
like Cyclin A and E2F1 in Eker-Cdc6-aRheb, where Cdk4/6 remained
active despite the absence of anchorages (Fig. 3). In the same cell,
Cyclin D1 mRNA accumulated fourfold, whereas the level of D3
mRNA was virtually unchanged and similar between the two cells.
3.4. Up-regulated Emi1 is at least partially responsible for the
stabilization of Cdc6
As shown above, the Emi1 gene was up-regulated, with elevated
levels of its protein product in the anchorage-deprived Eker-Cdc6-
aRheb (Figs. 2A and 3). Because APC/CCdh1 was a major ubiquitinEker REF cells constitutively expressing Cdc6 (REF-Cdc6 and Eker-Cdc6) and those
n MC [Anc()] and analyzed for the G1 cell cycle proteins and related factors by
-aRheb cultured in MC. In vitro assays of these kinase activities were carried out as
tive Rheb poorly proliferate in soft agar. REF-Cdc6, REF-Cdc6-aRheb, Eker-Cdc6 and
ve control.
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vated by Emi1 [4,7], we hypothesized that the elevated Emi1 was
responsible, at least partially, for the stabilization of Cdc6. There-
fore, we tested this idea initially by attempting Emi1 knockdown
in Eker-Cdc6-aRheb, but despite vigorous trials with various doses
(up to ﬁvefold over the dose sufﬁcient to transfect all of the cells) of
two sets of 23/27mer duplex siRNA constructs, there was no reduc-
tion in the level of Emi1 protein. Although under the same condi-
tions, virtually all of the cells were successfully transfected with
a ﬂuorescent labeled 23/27mer duplex control RNA. Therefore,
we modiﬁed our strategy by stably expressing Emi1 in REF-Cdc6
to a level comparable to that in Eker-Cdc6-aRheb and examined
its effects on Cdc6 levels. REF-Cdc6 expressing exogenous Emi1
(REF-Cdc6-Emi1) (roughly to a twofold higher level of Emi1 as esti-
mated by densitometry) and empty vector-introduced REF-Cdc6
were deprived of anchorage and analyzed likewise (Fig. 4A). As ex-
pected, expression of both Cdc6 and Cyclin A was partially restored
in REF-Cdc6-Emi1 despite translational repression, as indicated by
the diminished S6K1 Thr389 phosphorylation. To conﬁrm that Cdh1
was the target of the up-regulated Emi1 in Eker-Cdc6-aRheb, we
overexpressed Cdh1 in these cells and examined its effects
(Fig. 4B). As expected, both Cdc6 and Cyclin A disappeared upon
anchorage deprivation despite persistent mTORC1 activation and
three times more protein loading, as indicated by the intensities
of b-actin. These results indicate that the up-regulated Emi1 was
at least partially responsible for the stabilization of Cdc6 presum-
ably via inactivating APC/CCdh1 in Eker-Cdc6-aRheb, as established
[4].Fig. 4. Enforced Emi1 expression stabilizes, and Cdh1 overexpression destabilizes Cdc6
Emi1 (REF-Cdc6-Emi1) were incubated in MC and analyzed for the indicated factors by
cells (Eker-Cdc6-aRheb-Cdh1) were similarly analyzed as in (A). Roughly three times mo
show diminished levels of Cdc6 and Cyclin A. (C) APC/CCdh1 is inactive in anchorage-depr
Cdc6 and Eker-Cdc6-aRheb cultured for 24 h in MC and assayed for its ubiquitin ligase ac
described in Section 2. After an in vitro ubiquitylation reaction for 0, 10 and 50 min follo
with the anti-Cyclin A antibody.3.5. APC/CCdh1 is inactive in Eker-Cdc6-aRheb
To verify inactivation of APC/CCdh1 in Eker-Cdc6-aRheb, we
performed in vitro ubiquitylation assays of the APC/CCdh1 immuno-
precipitated from the anchorage-deprived REF-Cdc6 and Eker-
Cdc6-aRheb cell lysates. Their APC/CCdh1 activities were assayed
with Cyclin A as a substrate and compared with equal amounts
of immunoprecipitated Apc8, a key component of this ubiquitin
ligase complex (Fig. 4C). Consistent with the in vivo data, unlike
the results obtained for REF-Cdc6, APC/CCdh1 from the Eker-Cdc6-
aRheb was highly inactive, as conﬁrmed by performing assays with
various reaction times.
3.6. Inhibition of mTORC1 inactivates Cdk4/6 and destabilizes Cdc6
Finally, we investigated whether the Tsc2 inactivation- and/or
active Rheb expression-induced stabilization of Cdc6 was medi-
ated by mTORC1. When 24-h methylcellulose-cultured Eker-
Cdc6-aRheb was treated with rapamycin, Cdc6 was destabilized
with inactivation of Cdk4/6, as shown by a loss of Rb Ser780 phos-
phorylation and in vitro kinase assays (Fig. 5A). Consistent with
their inactivation, E2F-dependently expressed Cyclin A, E2F1 and
Emi1 also diminished or disappeared. On the other hand, all of
the D-type Cyclins decreased but were still present even after
24 h treatment with rapamycin. Quantitative RT-PCR analysis
showed that the levels of Cyclins D1 and D3 mRNAs were virtually
uninﬂuenced by rapamycin treatment. Thus, the levels of these
transcripts were not controlled by mTORC1.in anchorage-deprived cells. (A) REF-Cdc6 and REF-Cdc6 constitutively expressing
immunoblotting. (B) Eker-Cdc6-aRheb and Cdh1-overexpressing Eker-Cdc6-aRheb
re protein was loaded for immunoblot analysis of Eker-Cdc6-aRheb-Cdh1 to clearly
ived Eker-Cdc6-aRheb. APC/CCdh1 was immunoprecipitated from lysates of the REF-
tivities with Cyclin A as a substrate and for the amounts of co-precipitated Apc8 as
wed by separation by SDS gel electrophoresis, ubiquitylated Cyclin A was detected
Fig. 5. Inhibition of mTORC1 inactivates Cdk4/6 with diminished expression of the critical G1 factors in anchorage-deprived Eker-Cdc6-aRheb. (A) Eker-Cdc6-aRheb was
cultured for 24 h in MC, treated with or without 50 nM rapamycin for an additional 12 and 24 h and analyzed for the indicated factors by immunoblotting. In vitro kinase
assays were performed for Cdk2, Cdk4 and Cdk6 as in Fig. 2B. (B) Levels of Cyclins D1 and D3 transcripts are not controlled by mTORC1. D1 and D3 Cyclin mRNAs were
extracted from the Eker-Cdc6-aRheb cultured in MC with or without rapamycin as in (A) and quantiﬁed by real time RT-PCR and data processing as in Fig. 3. Circles and
squares denote D1 and D3 mRNAs, whereas closed and open symbols denote the mRNAs from the untreated and rapamycin-treated cells, respectively.
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The Tsc1/Tsc2-Rheb-mTORC1 pathway mediates growth fac-
tor and nutrient signals to control cell proliferation by regulat-
ing general translation [10]. Our studies with anchorage-
deprived rodent embryonic ﬁbroblasts indicate that the Tsc1/
Tsc2-Rheb-mTORC1 cascade is also critically involved in the
activation of Cdk4/6 to promote S phase onset, consistent with
a previous observation with a malignantly transformed cell line
[17]. Activated Cdk4/6 activates genes important or essential for
S phase onset including Cdc6, Cyclin A and Emi1, via the known
cascade involving Rb and E2F [3,4]. Induced Emi1 inhibits APC/
CCdh1, thereby stabilizing nascent Cdc6 and Cyclin A proteins
that are efﬁciently translated under S6K1 activation and 4EBP
inactivation.
In addition to regulating whole cell levels of D-type Cyclins,
as previously reported [18,19] and shown herein, how does
mTORC1 control Cdk4/6 activities? It is unclear at present, but
the association of neither D-type Cyclins nor p27Kip1 with these
kinases might be controlled by mTORC1. The involvement of p27
has been suggested in mTORC1 control of cell cycle progression
in some cells [20,21]. In our experiments, however, the whole
cell level of p27 was rather reduced by treatment with rapamy-
cin, which led to inactivation of Cdk4/6 (Fig. 5A). Moreover,
when we tentatively analyzed the quantity of the D-type Cyclins
and the p27 bound to the Cdk4/6 from rapamycin-treated and
untreated Eker-Cdc6-aRheb, their quantities were similar regard-
less of the treatment (unpublished data). This result provision-
ally suggests that at least the quantities of these Cyclins and
the inhibitor associated with Cdk4 might be neither directly re-
ﬂected by their levels in the whole cell nor regulated by
mTORC1.
One realistic scenario raised in this study is that an anchor-
age signal might actually be mediated by the mTORC1 pathway,
and the rationale for this is as follows. Anchorage deprivation
markedly reduced S6K1 Thr389 phosphorylation, indicative of
mTORC1 inactivation, whereas activation of mTORC1 by a Tsc2
mutation or active Rheb overexpression suppressed virtually all
of the effects of anchorage deprivation on the G1 cell cycle
factors. Consistent with this scenario, we have tentatively iden-
tiﬁed Rho-associated kinase as a candidate for the molecule that
directly links the anchorage signal to Tsc2 (Park et al.,
unpublished).Acknowledgments
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